Skip to Content

Tivozanib (Fotivda) for Relapsed or Refractory Advanced Renal Cell Carcinoma

About this PQI

The purpose of this PQI is to review the clinical considerations around the use of tivozanib (Fotivda®) for patients with relapsed or refractory advanced renal cell carcinoma.

More About This PQI

PQI in Action Articles:

How to Use a Positive Quality Intervention (PQI)

Essentially, it’s a tool to improve patient care by sharing best practices in oncology care. Consider this standardized, peer-review clinical guidance to oncology healthcare teams, enabling you and your team to consistently deliver high-quality care to your patients.

Find a PQI